This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Sep 2026 quarter revenue falls from Rs 11.11 lakh a year ago to Rs 9.11 lakh
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone revenue from operations for the quarter ended 30 September 2026 was Rs 9.11 lakh versus Rs 11.11 lakh in the same quarter a year earlier, down 18%. The quarter's profit after tax was Rs 0.54 lakh, and core operating margin widened. Standalone half-year profit before tax rose to Rs 1.64 lakh from Rs 1.08 lakh. The auditor stepped down, and SGAG took over mid-year; SGAG reviewed the quarter, while another auditor reviewed the June quarter.
Lower sales may weigh on the stock, but better cost control widened margins. The auditor change may draw scrutiny, while profit remains low.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹0.13 Cr | ₹0.07 Cr | +76.1% |
| Operating profit | ₹0.01 Cr | ₹0.01 Cr | +64.6% |
| Profit after tax | ₹0.01 Cr | ₹0.01 Cr | +59.7% |
| EBITDA margin | 39.4% | 63.0% | −23.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.